FOXO1 and metabolic dysfunction-associated steatotic liver disease: In MASLD patients, increased levels of miR-223 in the liver were observed, along with a decrease in FOXO1 mRNA suggesting a potential role for miR-223 in the regulation of metabolic processes in the liver [63].